Bayer aligns organization with Life Science businesses

MOSCOW (MRC) -- Following the economic and legal separation of Covestro, Bayer is charting the course for its successful development as a Life Science company, said the company on its site.

Supervisory Board approved the reorganization proposed by the Board of Management. From January 1, 2016, the company’s business will be managed by three divisions: Pharmaceuticals, Consumer Health and Crop Science. The present structure of a strategic management holding company and operational subgroups will be replaced by an integrated organization under the umbrella of the strong Bayer brand.

In the new organization, the Board of Management of Bayer AG will also hold overall responsibility for business operations. For this reason, the Supervisory Board resolved to appoint the heads of the divisions - Dieter Weinand (Pharmaceuticals), Erica Mann (Consumer Health) and Liam Condon (Crop Science) - to the Board of Management effective January 1, 2016. On the same date, Dr. Hartmut Klusik will also join the Board of Management of Bayer AG as the new Labor Director and Board member responsible for Human Resources, Technology and Sustainability. He will succeed Michael Konig, who has requested that his contract not be extended.

As part of the reorganization, the Bayer HealthCare subgroup will be dissolved. The Radiology business will be assigned to the Pharmaceuticals Division. Consumer Health will comprise the present Consumer Care Division. The Bayer CropScience subgroup will become the Crop Science Division. As a business unit, Animal Health will report directly to Liam Condon.

The divisions are to focus on core competencies close to their businesses - research and development, production, and sales & marketing. They will be supported by integrated functions such as Human Resources and Procurement, and by global services. Within this context, Bayer’s existing Technology Services company will become the Engineering & Technology function. Bayer Business Services, the company in which information technology and business support services are bundled, will remain a separate legal entity that is to see further expansion.

This greater integration will also be reflected in Bayer’s brand architecture. In the future, the company will focus exclusively on the Bayer corporate brand and its product brands. The divisions will not have separate brand identities.

As MRC informed earlier, the plan for Bayer MaterialScience to become a separate company was announced in September 2014.

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. As an innovation company, it sets trends in research-intensive areas. Bayer's products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2014, the Group employed 118,900 people and had sales of EUR 42.2 billion.

All closing conditions for acquisition of three BASF sites satisfied

MOSCOW (MRC) -- All closing conditions on the path toward Siegfried's acquisition of BASF's pharmaceutical supply business have been fulfilled. They include regulatory assurance issued by Swissmedic that the necessary approval for the Evionnaz production site will be provided in time for the closing, as per 4-traders.

Siegfried assumes that the agreements between Siegfried and BASF (closing) and the connected transfer of the chemical-pharmaceutical production sites in France, Germany and Switzerland will be enforced as planned on September 30, 2015.

The Siegfried Group is active worldwide in the field of Life Sciences with production facilities located in Switzerland, Germany, China, Malta and in the USA. At the end of 2014, Siegfried reported annual sales of CHF 315 million and employs at the time being approximately 1400 employees. Siegfried Holding AG is listed on the Swiss Exchange.

Siegfried is active in both the primary and secondary production of drugs. The company develops and manufactures active pharmaceutical ingredients for the research-based pharmaceutical industry as well as the corresponding intermediate steps and controlled substances, and provides development and production services for drugs in finished dosage forms including sterile filling.

As MRC informed earlier, BASF began its first production of diphenylmethane diisocyanate (MDI) at its wholly-owned site in Chongqing, China. Production will be ramped up gradually in line with market demand.

BASF is the largest diversified chemical company in the world and is headquartered in Ludwigshafen, Germany. BASF produces a wide range of chemicals, for example solvents, amines, resins, glues, electronic-grade chemicals, industrial gases, basic petrochemicals and inorganic chemicals. The most important customers for this segment are the pharmaceutical, construction, textile and automotive industries. BASF had sales of over EUR74 billion in 2014 and over 113,000 employees as of the end of the year.

Carbios starts production of biodegradable plastics at its pilot plant in France

MOSCOW (MRC) -- French green chemistry company Carbios, a chemistry company specializing in technologies dedicated to recovering plastic waste and producing bio-polymers, has started pilot production of biodegradable plastics, with a capacity of 40kg per hour, using its enzyme-based technology, said Chemicals-technology.

The new pilot plant is located at the company's headquarters in Saint-Beauzire, Auvergne, in central France. The new plant can convert polymers in plastics back to their original form, making them highly recyclable.

"Having a plastic production platform at our headquarters enables us to quickly take these first applications to the industrial and commercial stage."

Last year, Carbios developed its enzyme-based technology. In early 2015, with the help of the CRITT Bio-Industries (Regional Center for Innovation and Technology Transfer) in Toulouse, the company produced enzymes at the pilot scale of 300l.

Carbios, currently ahead of its original development schedule, received the fund to build the pilot plant from its December 2013 initial public offering.

Carbios CEO Jean-Claude Lumaret said: "After the announcement in July 2014 of the successes we obtained with the first self-destructible plastic films that included Carbios' enzyme-based technology, the next step was to develop formulations for these plastic materials based on the specific properties required by each application.
"Having a plastic production platform at our headquarters enables us to quickly take these first applications to the industrial and commercial stage, and to strengthen our intellectual property with the patents developed for each new approved application."

With the new platform, Carbios has obtained the tools and skills required to make its technology an industry reality.
The company is able to demonstrate its biodegradation technology for first applications, including plastic films, mulching films for agriculture, and plastic bags at the pre-industrial stage.

As it was said earlier, Carbios reported that it has successfully managed to depolymerize 90 percent of the polylactic acid (PLA) material in 48 hours through the use of its enzymatic process.


Shanghai Pret Composites announces North American TPO expansion

MOSCOW (MRC) -- Shanghai Pret Composites, which acquired WPR Holdings LLC (Wellman Plastics Recycling) of Johnsonville, S.C. earlier this year, has announced that the new name of its US operating unit will be Wellman Advanced Materials and that it will benefit from a capacity expansion of 20,000 tons of TPOs (thermoplastic polyolefins), reported Plastemart.

The new capacity expansion of 44-million pounds/20,000 tonnes at the Johnsonville site in order to offer Pret's highly regarded TPO, long-glass (reinforced) polypropylene (LGPP), and other engineered polypropylene (PP) compounds to automakers and tier suppliers in North America.

The first compounding extruder will be installed by the end of 2015 with a second to be installed in early 2016. Wellman also plans to expand its product development and application testing services at its R&D facility in Johnsonville with testing equipment with more in-house mechanical testing, material characterization, and color-matching resources. Moldfilling and structural analysis support will also be offered for its North American customers.

"The name change is to signify that Wellman Advanced Materials' product portfolio in North America has been expanded to include TPOs and various engineered polypropylene compounds in addition to Wellman’s traditional nylon products," explained Xy Sun, chief-executive officer, Wellman Advanced Materials.

We remind that, as MRC wrote previously, Johns Manville (JM) has announced plans to significantly expand capacity at its Scottsboro, Ala., TPO manufacturing facility. JM completed construction at the Scottsboro plant in April 2015, increasing overall TPO production capacity by 20%. JM is a global building and specialty products manufacturer and Berkshire Hathaway company, a leader in the commercial roofing market for decades, offering a full line of products including built-up, modified asphalt, polyiso and single ply systems.

Shanghai PRET Composites Co., Ltd. researches, develops, manufactures, distributes, sells, and services high performance plastics and composites. Its products include polypropylene series of high-performance materials, styrene copolymer material series, polycarbonate alloy series, polyamide and the thermoplastic polyester engineering plastics, liquid crystal polymer materials, modified polyolefins, modified acrylonitrile butadiene styrenes, plastic alloy products, and other products. The company markets its products under the PRET brand name primarily in China. Its products are used in automobile parts, household electric appliances, and telecommunication industry. The company was founded in 1993 and is based in Shanghai, China.

Lanxess included in Dow Jones Sustainability Index World for the fifth consecutive time

MOSCOW (MRC) -- As of September 21, 2015, specialty chemicals company Lanxess was listed in the Dow Jones Sustainability Index (DJSI) World for the fifth time in a row, said the producer on its site.

The composition of the well-renowned sustainability index is determined once a year according to financially material environmental, social and governance factors.

The index follows the "best in class" principle: only the top 10 percent of the companies assessed in each industry sector are included in the DJSI World. In this year, Lanxess was especially recognized for its commitment in the areas occupational health and safety, codes of conduct and compliance, risk and crisis management, customer relationship management, corporate citizenship as well as innovation management.

The DJSI is compiled by S&P Dow Jones Indices, one of the world’s leading providers of financial market indices, in cooperation with RobecoSAM, an asset manager specialized in sustainability investing. In this year, the world’s largest 3,400 companies from developed and emerging markets were invited to take part in the assessment.

As MRC reported earlier, Saudi Arabia's state oil company is taking a 50%-stake in the synthetic rubber business of German chemicals groups Lanxess in a deal that values the entire unit at EUR2.75bn, including debt. Saudi Aramco will pay around EUR1.2bn in cash for the stake. The transaction still requires the approval of the relevant antitrust authorities and is expected to be completed in the first half of 2016.

Lanxess is a leading specialty chemicals company with sales of EUR 8.0 billion in 2014 and about 16,600 employees in 29 countries. The company is currently represented at 52 production sites worldwide. The core business of Lanxess is the development, manufacturing and marketing of plastics, rubber, intermediates and specialty chemicals.